Clinical Trials in Boston

Showing 2361-2380 of 17,836 trials

CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis

NCT07388277

The purpose of this study is to evaluate the safety of CC-97540 in relapsed or refractory severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

Antineutrophil Cytoplasmic Antibody-associated Vasculitis

Marcela V. Maus, M.D.,Ph.D.12 participantsStarted Jul 2026

Boston, Massachusetts, United States

COMPLETEDPhase 4< 1 mile

COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure

NCT05734690

This is a randomized, open-label, initiative within the Mass General Brigham healthcare system testing two remote care strategies for optimizing the prescription of guideline-directed medical therapies in patients with heart failure, regardless of left ventricular ejection fraction (LVEF).

Heart Failure

Brigham and Women's Hospital503 participantsStarted May 2023

Boston, Massachusetts, United States

COMPLETEDPhase 4< 1 mile

Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users

NCT04995029

The primary objective of the induction phase of the study is to compare treatment retention of participants following rapid induction or standard of care (SoC) induction onto extended-release buprenorphine. The primary objective of the maintenance phase is to compare the efficacy of 100 mg and 300 mg maintenance doses of extended-release buprenorphine administered every 4 weeks.

Moderate to Severe Opioid-use Disorder

Indivior Inc.785 participantsStarted Oct 2021

Garden Grove, California, United States • Panorama City, California, United States • San Diego, California, United States +26 more locations

CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis

COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure

Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users

Find Trials by Condition in Boston

CLOZAPINE Response in Biotype-1

Vincristine Pharmacokinetics in Infants

Impact of Metabolic Health on Sperm Epigenetic Marks in Humans

Androgen-responsive POSLUMA-guided Intra-prostatic Boost

Efficacy of Routine Saline Flushing in the Prevention of Nephrostomy Tube Obstructions: A Pilot Study

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

Registry of the Patient Experience for Carpal Tunnel Release

A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight

A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition

Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity

A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

Speech-Evoked Auditory Potentials: Multisite Pediatric Evaluation

Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma